Aptinyx Inc reported $4.93M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Biogen BIIB:US $ 654.1M 16.8M
Cara Therapeutics CARA:US $ 5.88M 262K
Daiichi Sankyo 4568:JP 84.5B 5.38B
Eli Lilly And LLY:US $ 1.58B 107.8M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Marinus Pharmaceuticals MRNS:US 9.45M 2.62M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M